Efficacy and Safety of Diclofenac 1.16% Gel in Subjects With Acute Neck Pain

计划入组 72 人 · 首次发布于 2011 年 4 月 14 日

Immunogenicity and Safety Study of Monovalent Omicron XBB.1.5 Vaccine as a Booster in Adults

首次发布于 2024 年 8 月 22 日

A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination

计划入组 3,100 人 · 首次发布于 2023 年 6 月 20 日

PHH-1V81

XBB-202

XBB.1.5 RBD subunit vaccine

CanSino Biologics Inc.

China

BBB-Therapeutics B.V.

Netherlands

HC-116 Eddie Dowling Highway, LLC

United States

Novavax COVID-19 Vaccine Receives FDA Emergency Use Authorization for 2023-2024 Formula

Novel Trivalent COVID-19 Vaccine Shows Robust Cross-Protection Against XBB Variants

FDA Authorizes Second Omicron Booster for High-Risk Groups, Simplifies COVID-19 Vaccine Strategy